Recombinant Human FLT4 Protein (ECD), Fc-His-tagged(C-ter)
Cat.No. : | FLT4-101H |
Product Overview : | Recombinant Human FLT4 Protein (ECD) with Fc-His tag (C-ter) was expressed in HEK293. |
- Specification
- Gene Information
- Related Products
- Download
Description : | This gene encodes a tyrosine kinase receptor for vascular endothelial growth factors C and D. The protein is thought to be involved in lymphangiogenesis and maintenance of the lymphatic endothelium. Mutations in this gene cause hereditary lymphedema type IA. [provided by RefSeq, Jul 2008] |
Source : | HEK293 |
Species : | Human |
Tag : | His&Fc |
Form : | Powder |
Protein length : | Tyr25-Ile776 |
Endotoxin : | Endotoxin level is less than 0.1 EU/μg of the protein, as determined by the LAL test. |
Purity : | > 95% (by SDS-PAGE) |
Applications : | Binding, SDS-PAGE |
Notes : | For laboratory research only, not for drug, diagnostic or other use. |
Storage : | Lyophilized protein should be stored at -20°C or -80°C. After reconstitution, aliquot and store at -20°C for up to one month, at 2-8°C for up to one week. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. |
Storage Buffer : | PBS (pH 7.4) |
Reconstitution : | Reconstitute to a concentration of 0.1-0.5 mg/ml in sterile distilled water. |
Gene Name : | FLT4 fms-related tyrosine kinase 4 [ Homo sapiens ] |
Official Symbol : | FLT4 |
Synonyms : | FLT4; fms-related tyrosine kinase 4; vascular endothelial growth factor receptor 3; PCL; VEGFR3; FLT-4; VEGFR-3; soluble VEGFR3 variant 1; soluble VEGFR3 variant 2; soluble VEGFR3 variant 3; fms-like tyrosine kinase 4; tyrosine-protein kinase receptor FLT4; FLT41; LMPH1A; |
Gene ID : | 2324 |
mRNA Refseq : | NM_002020 |
Protein Refseq : | NP_002011 |
MIM : | 136352 |
UniProt ID : | P35916 |
Products Types
◆ Recombinant Protein | ||
FLT4-2021R | Recombinant Rat FLT4 Protein, His (Fc)-Avi-tagged | +Inquiry |
FLT4-4378H | Active Recombinant Human FLT4 Protein, GST-tagged | +Inquiry |
FLT4-2055H | Recombinant Human FLT4 Protein, Fc/His-tagged | +Inquiry |
FLT4-4377H | Active Recombinant Human FLT4 Protein, GST/His-tagged | +Inquiry |
FLT4-5232H | Recombinant Human FLT4 protein, His-Avi-tagged | +Inquiry |
◆ Lysates | ||
FLT4-2016MCL | Recombinant Mouse FLT4 cell lysate | +Inquiry |
FLT4-2709HCL | Recombinant Human FLT4 cell lysate | +Inquiry |
Related Gene
Not For Human Consumption!
Inquiry
- Reviews
- Q&As
Customer Reviews (3)
Write a reviewThe catalytic activity of FLT4 is very strong, which can significantly improve the selectivity and yield of chemical reactions, and its application potential is great.
We were reassured that the quality of FLT4 was consistent.
Using FLT4 for experiments, I can focus more on experimental design and data analysis without worrying about the reproducibility of experimental results.
Q&As (6)
Ask a questionFLT4 protein is associated with various tumor-related markers such as malignant lymphoma, breast cancer, and lung cancer.
FLT4 protein is a key regulator of lymphedema and plays an important role in lymphangiogenesis and lymphatic drainage.
Yes, mutations in the FLT4 protein can lead to congenital lymphedema, a condition caused by abnormal lymphatic vessel development.
The protein is considered an important target in anticancer therapy, and inhibition of its activity may reduce tumor angiogenesis and metastasis.
FLT4 protein plays an important role in pulmonary hypertension, and upregulation of its activity may lead to pathological changes such as vascular remodeling and pulmonary artery stenosis.
This is involved in the regulation of angiogenesis and lymphangiogenesis by binding to vascular endothelial growth factor C (VEGF-C) and vascular endothelial growth factor D (VEGF-D).
Ask a Question for All FLT4 Products
Required fields are marked with *
My Review for All FLT4 Products
Required fields are marked with *
Inquiry Basket